BIOCURIE
Live / Allowed — Published for opposition (as of 18 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99704470
- Mark type
- Stylized text
- Filed
- 16 Mar 2026
- Published for opposition
- 18 Aug 2026
- Attorney of record
- John McCormick
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for use in the field of biotechnology, biopharmaceutical, and pharmaceuticals research, development, manufacturing, production, and quality control; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in the field of biotechnology, biopharmaceutical, and pharmaceuticals research, development, manufacturing, production, and quality control; Platform as a service (PAAS) featuring computer software platforms for featuring artificial intelligence (AI) software for use in the field of biotechnology, biopharmaceutical, and pharmaceuticals research, development, manufacturing, production, and quality control; Platform as a service (PAAS) featuring computer software platforms for use in the field of biotechnology, biopharmaceutical, and pharmaceuticals research, development, manufacturing, production, and quality control; Software as a service (SAAS) services featuring software for optimizing, monitoring, and scaling the research, development, manufacturing, production, and quality control of biotechnology, biopharmaceutical, and pharmaceuticals; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for optimizing, monitoring, and scaling the research, development, manufacturing, production, and quality control of biotechnology, biopharmaceutical, and pharmaceuticals; Software as a service (SAAS) services featuring software for simulating the research, development, manufacturing, production, and quality control of biotechnology, biopharmaceutical, and pharmaceuticals; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for simulating the research, development, manufacturing, production, and quality control of biotechnology, biopharmaceutical, and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for simulating the research, development, manufacturing, production, and quality control of biotechnology, biopharmaceutical, and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for featuring artificial intelligence (AI) software for simulating the research, development, manufacturing, production, and quality control of biotechnology, biopharmaceutical, and pharmaceuticals; Scientific research and development; Scientific and technological services, namely, research and design in the field of artificial intelligence for biotechnology, biopharmaceutical, and pharmaceuticals research, development, manufacturing, production, and quality control; Scientific and technological services, namely, research and design in the field of mechanistic modeling for biotechnology, biopharmaceutical, and pharmaceuticals research, development, manufacturing, production, and quality control; Pharmaceutical research and development
Owner
- BioCurie, Inc., Wilmington, DE, US
- BioCurie, Inc., Wilmington, DE, US
Prosecution history
- 18 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Aug 2026 — PUBLISHED FOR OPPOSITION
- 12 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jul 2026 — ASSIGNED TO EXAMINER
- 16 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 16 Mar 2026 — NEW APPLICATION ENTERED